HB 703: Providing Notice Of The Introduction Of New High-cost Prescription Drugs

HB 703: Providing Notice Of The Introduction Of New High-cost Prescription Drugs

This bill requires prescription drug manufacturers to provide certain notice to the office of the attorney general if they are introducing a new prescription drug to market at a wholesale acquisition cost that exceeds the threshold set for a specialty drug under the Medicare Part D program.

New Futures supports HB 703. Click here to read.

Bill Status
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote